PD-L1 testing in gastric cancer

被引：0
|
作者：
Ushiku, Tetsuo [1 ]
机构：
[1] Univ Tokyo, Dept Pathol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY12-4
引用
收藏
页码：S1361 / S1361
页数：1
相关论文
共 50 条
  • [1] PD-L1 testing in breast cancer
    Horii, Rie
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1361 - S1361
  • [2] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    [J]. ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [3] Optimized PD-L1 scoring of gastric cancer
    Birgid Schoemig-Markiefka
    Jana Eschbach
    Andreas H. Scheel
    Aylin Pamuk
    Josef Rueschoff
    Thomas Zander
    Reinhard Buettner
    Wolfgang Schroeder
    Christiane J. Bruns
    Heike Loeser
    Hakan Alakus
    Alexander Quaas
    [J]. Gastric Cancer, 2021, 24 : 1115 - 1122
  • [4] Optimized PD-L1 scoring of gastric cancer
    Schoemig-Markiefka, Birgid
    Eschbach, Jana
    Scheel, Andreas H.
    Pamuk, Aylin
    Rueschoff, Josef
    Zander, Thomas
    Buettner, Reinhard
    Schroeder, Wolfgang
    Bruns, Christiane J.
    Loeser, Heike
    Alakus, Hakan
    Quaas, Alexander
    [J]. GASTRIC CANCER, 2021, 24 (05) : 1115 - 1122
  • [5] Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
    Imai, Yushi
    Chiba, Tetsuhiro
    Kondo, Takayuki
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Ao, Junjie
    Kojima, Ryuta
    Kusakabe, Yuko
    Nakamura, Masato
    Saito, Tomoko
    Nakagawa, Ryo
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Tawada, Akinobu
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kato, Jun
    Kotani, Ai
    Matsubara, Hisahiro
    Kato, Naoya
    [J]. ONCOLOGY LETTERS, 2020, 20 (03) : 2161 - 2168
  • [6] PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
    Katerina Ancevski Hunter
    Mark A. Socinski
    Liza C. Villaruz
    [J]. Molecular Diagnosis & Therapy, 2018, 22 : 1 - 10
  • [7] PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
    Hunter, Katerina Ancevski
    Socinski, Mark A.
    Villaruz, Liza C.
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2018, 22 (01) : 1 - 10
  • [8] The association of lentinan with PD-1/PD-L1 axis in gastric cancer
    Ina, K.
    Kataoka, T.
    Ina, H.
    Yoneda, M.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 212 - 212
  • [9] TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer
    Henick, Brian S.
    Moy, Ryan H.
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [10] PD-L1 testing in triple negative breast cancer
    Dobritoiu, F.
    Chefani, A.
    Billingham, K.
    Chenard, M.
    Vaziri, R.
    Lacroix-Triki, M.
    Waydelich, A.
    Erb, G.
    Toro, P.
    Wedden, S.
    D'Arrigo, C.
    [J]. VIRCHOWS ARCHIV, 2019, 475 : S17 - S18
12345